Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy

Area of Science:

• Cardiology
• Epigenetics
• Molecular Biology

Background:

• Cardiac hypertrophy involves complex signaling pathway alterations and gene reprogramming.
• Epigenetic modifications like DNA methylation and histone modification are implicated in cardiac dysfunction.
• Non-coding RNAs (ncRNAs) play a role in gene expression modulation during cardiac pathologies.

Purpose of the Study:

• To review the association between ncRNAs and epigenetic modifications in cardiac hypertrophy.
• To discuss the crosstalk between ncRNAs and epigenetic mechanisms in the heart.
• To explore the therapeutic and diagnostic potential of ncRNA-epigenetic interactions in hypertrophic heart disease.

Main Methods:

• Literature review of current research on ncRNAs and epigenetics in cardiac hypertrophy.
• Analysis of studies detailing epigenetic modifications (DNA methylation, histone modification, etc.).
• Examination of evidence linking ncRNAs to chromatin state changes and cardiac pathologies.

Main Results:

• Emerging evidence highlights the functional significance of ncRNAs in modulating gene expression during cardiac hypertrophy.
• ncRNAs may act as signals influencing chromatin state, but mechanisms are largely unexplored.
• Crosstalk between ncRNAs and epigenetic modifications is crucial in cardiac hypertrophy.

Conclusions:

• ncRNAs and epigenetic modifications are intricately linked in cardiac hypertrophy.
• Understanding this crosstalk offers potential for novel diagnostic markers and therapeutic targets.
• Further research is needed to fully elucidate ncRNA-mediated epigenetic regulation in hypertrophic heart disease.